Broadcom Inc (AVGO) Stock Price Today
Aura AI Summary
Key Stats
- $1.81TMarket Cap
- -Volume
- TechnologySector
- $481.5752W High
- $288.6452W Low
- -Typical Hold Time
- $1.86TEnterprise Value
- 0.68%Div Yield
- -Trading Activity
Track Broadcom Inc (AVGO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Broadcom Inc has traded between a low of $288.64 and a high of $481.57, highlighting its annual price range. Buy and sell Broadcom Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Broadcom Inc
Broadcom--the combined entity of Broadcom and Avago--boasts a highly diverse product portfolio across an array of end markets. Avago focused primarily on radio frequency filters and amplifiers used in high-end smartphones, such as the Apple iPhone and Samsung Galaxy devices, in addition to an assortment of solutions for wired infrastructure, enterprise storage, and industrial end markets. Legacy Broadcom targeted networking semiconductors, such as switch and physical layer chips, broadband products (such as television set-top box processors), and connectivity chips that handle standards such as Wi-Fi and Bluetooth. The company has acquired Brocade, CA Technologies, Symantec's enterprise security business, and has a pending deal to acquire VMware to bolster its offerings in software.
Most Recent News
Altisource CEO buys shares amid 19% revenue rise and AI-driven efficiency boost
Altisource Portfolio Solutions' CEO Shepro William B purchased 4,000 shares, increasing his stake to 8,686 shares, signaling confidence in the company's future. The company reported a 19% year-over-year increase in Q2 2026 service revenue to $48.70 m...

Access barriers limit Xphozah uptake despite nephrologists' willingness to triple use, with reimbursement changes ahead.
New research from Spherix Global Insights reveals that access barriers, not drug efficacy, restrict the use of Ardelyx's Xphozah for dialysis patients with hyperphosphatemia. Nephrologists say they would nearly triple Xphozah prescriptions if reimbur...

Plug Power stock surged 83% early 2026 but lost all gains by midyear, raising questions on its outlook.
Plug Power's stock price jumped 83% in the first five months of 2026, reflecting strong investor enthusiasm for hydrogen energy. However, by midyear, the stock gave back all those gains, returning to its earlier levels. This volatility highlights the...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.